Graftworx, Inc. dba Alio
Alio, Inc. is a medical technology company focused on reinventing the management of chronic diseases through non-invasive, wireless remote patient monitoring. Their flagship product, the SmartPatch, is the world's first non-invasive potassium monitor, designed to provide continuous health metrics for patients, particularly those with chronic kidney disease.
Industries
Nr. of Employees
small (1-50)
Graftworx, Inc. dba Alio
10901 W. 120th Ave, Suite 380, Broomfield, CO 80021 USA
Patents
Systems and methods for measuring biological metrics and blood vessel geometry using a multiple optical path photoplethysmography device
US-11937906-B2
View Details
Systems and methods for measuring biological metrics and blood vessel geometry using a multiple optical path photoplethysmography device
US-11937906-B2
View DetailsProducts
Multi‑metric wearable patch and remote monitoring platform
A wearable patch-based remote monitoring platform that non‑invasively and continuously collects multiple clinical‑grade metrics (electrolytes and blood indices plus basic vitals), transmits data to a cloud hub, and presents results via a clinician portal with alerting and population views.
Multi‑metric wearable patch and remote monitoring platform
A wearable patch-based remote monitoring platform that non‑invasively and continuously collects multiple clinical‑grade metrics (electrolytes and blood indices plus basic vitals), transmits data to a cloud hub, and presents results via a clinician portal with alerting and population views.
Services
Design and execution of multi‑site clinical studies and feasibility validations to evaluate accuracy, clinical utility, and health‑economic impact of remote monitoring technology (examples include WEAR and JEM studies).
Implementation, onboarding, and integration of a remote monitoring platform with clinical workflows and partner care‑platforms, including clinician portal configuration and population health views.
Design and execution of multi‑site clinical studies and feasibility validations to evaluate accuracy, clinical utility, and health‑economic impact of remote monitoring technology (examples include WEAR and JEM studies).
Implementation, onboarding, and integration of a remote monitoring platform with clinical workflows and partner care‑platforms, including clinician portal configuration and population health views.
Expertise Areas
- Remote patient monitoring for chronic disease
- Nephrology and dialysis patient monitoring
- Clinical study design and multi‑center validation
- Regulatory 510(k) strategy and compliance
Key Technologies
- Wearable multi‑parameter patch sensors
- Digital auscultation (remote stethoscope)
- AI‑driven signal processing and analytics
- Cloud‑based clinician portal and hub
News & Updates
A summary of Alio's achievements and milestones throughout 2023, including FDA clearances and partnerships.
Initial findings from studies showing the effectiveness of Alio's platform in monitoring CKD patients.
Alio received FDA clearance for its SmartPatch, enabling non-invasive monitoring of potassium, hematocrit, and hemoglobin.
A summary of Alio's achievements and milestones throughout 2023, including FDA clearances and partnerships.
Initial findings from studies showing the effectiveness of Alio's platform in monitoring CKD patients.
Alio received FDA clearance for its SmartPatch, enabling non-invasive monitoring of potassium, hematocrit, and hemoglobin.